OMRI - Omrix Biopharmaceuticals Incorporated

Your Recent Quotes: 0 | 0
Price Glossary Definition
24.99 -0.03
-0.12%
12/30/08 4:00
Open
24.99
Prev Close
25.02
Volume
144,828
52 Wk. Range
8.99- 36.30
Year-to-Date Performance Glossary Definition
DOWN -28.07%
Latest Dividend for OMRI
Dividend
N/A
Yield
0.00
Ex-Date
N/A
Price/Earnings Comparisons Glossary Definition
 
35.20
 
36.20
 
13.50
OMRI
Sect. Av.
S&P 500
Market Cap
428,078,700
Outstanding Shares
17,114,000
TheStreet Rating Glossary Definition
  • A
  • B
  • C
  • D
  • E
Buy OMRI Rating Report
Target Price (1Yr)
High
29.00
Revenue
0

Annual Dividend
Rate
0.00
Yield
0.00
Growth
12 Month
3 Year
CAGR
Revenue
-3.20
2.09
0.45
Net Income
-48.20
-2.81
0.00
EPS
-58.20
-1.37
0.00

Stock Performance History
 
3 Month
1 Year
3 Year
Price Change
39.30
-27.63
0.00
Earnings Per Share($)

12/2005
 
 
 
-2.01
12/2006
 
 
 
1.68
12/2007
 
 
 
0.71

Earnings for OMRI
EBITDA
7,203,000
Revenue
61,705,000
Outside Analyst Rating History

1/9/09
1
Buy
1/9/09
4
Hold
1/9/09
0
Sell

Jim Cramer Portfolio
Find out now if OMRI is in Jim's personal portfolio at Action Alerts PLUS.

Price & Volume

Latest OMRI Headlines
Johnson & Johnson says Omrix shareholders tendered about 97.8% of shares.

2:59PM 12/27/08

To Marek Fuchs, it's plain to see that some business journalists are overdoing it on a good but small acquisition by Johnson & Johnson.

11:23AM 11/25/08

Video
Stocks on Wall Street rally on news of a federal plan to rescue ailing financial giant Citigroup and the appointment by President-elect Obama of several key economic advisers. Frank Curzio reviews the action in The Real Story video (above).

4:28PM 11/24/08

Premarket futures were hinting at a higher open for U.S. stocks Monday, following a U.S. government plan to rescue ailing financial giant Citigroup.

9:15AM 11/24/08

Johnson & Johnson plans to begin a tender offer to Omrix shares for $25 each. Omrix closed Friday at $21.16.

6:55AM 11/24/08

Seattle Genetics rises, but Alnylam falls.

4:01PM 10/27/08

King Pharmaceuticals bucks an otherwise dismal day in health stocks.

5:27PM 10/09/08

Genentech shares drop on investor concerns about financing for the company's deal with Roche but ease off their lows by the closing bell.

5:19PM 10/08/08

Shares of the company drop after announcing late-stage trial results that disappoint the Street.

5:59PM 08/12/08

Aqua America, Raymond James Financial, Steelcase, Morningstar and Liberty Media Capital all downgraded.

7:19AM 04/02/08

Understanding the Market

Our Experts' Take at RealMoney for Omrix Biopharmaceuticals Incorporated
Traders are cycling back into 'slow motion' stocks and realizing that they oversold Wal-Mart.

12:39PM 01/09/09

Once again, sentiment is in the driver's seat.

8:58AM 01/09/09

More Experts' Takes on OMRI


Premium Stock Ideas
Is Cramer trading OMRI in his Action Alerts Plus Portfolio?